Edition:
United States

Chimerix Inc (CMRX.OQ)

CMRX.OQ on NASDAQ Stock Exchange Global Market

4.02USD
4:00pm EDT
Change (% chg)

$-0.04 (-0.99%)
Prev Close
$4.06
Open
$4.06
Day's High
$4.09
Day's Low
$4.01
Volume
40,168
Avg. Vol
239,786
52-wk High
$58.00
52-wk Low
$3.50

CMRX.OQ

Chart for CMRX.OQ

About

Chimerix, Inc. (Chimerix) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing oral antivirals. The Company, based on its lipid conjugate technology, has developed its lead compound, brincidofovir (BCV, CMX001), which is in Phase III clinical development. In addition, the Company... (more)

Overall

Beta: --
Market Cap(Mil.): $187.63
Shares Outstanding(Mil.): 46.21
Dividend: --
Yield (%): --

Financials

  CMRX.OQ Industry Sector
P/E (TTM): -- 41.28 37.71
EPS (TTM): -2.68 -- --
ROI: -42.46 -9.20 14.43
ROE: -42.49 -9.24 15.61

BRIEF-Chimerix Q1 loss per share $0.57

* Chimerix Announces Top-Line Interim AdVise Data and First Quarter 2016 Financial Results

May 09 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.